Neuren Pharmaceuticals | NEU - Cost Of Sales


Neuren Pharmaceuticals reported AUD7.45M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Clinuvel Pharmaceuticals AUD 2.64M 1.06M Dec/2025
Genetic Signatures AUD 6.26M 3.95M Dec/2025
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
Medical Developments International AUD 7.09M 4.91M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organon & Co USD 711M 34M Jun/2026
Starpharma Holdings AUD 417K 459K Dec/2025
Telix Pharmaceuticals AUD 245.71M 24.35M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026